Late-breaking Data Demonstrate AHA/ACC Guideline-directed CCTA ± FFRCT Precision Pathway is Superior to Traditional Testing
06 nov. 2022 19h00 HE
|
HeartFlow Holding, Inc.
MOUNTAIN VIEW, Calif., Nov. 06, 2022 (GLOBE NEWSWIRE) -- HeartFlow, Inc., the leader in revolutionizing precision heartcare, today announced new trial results that show evaluating patients with...